Palvella Therapeutics Inc (PVLA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
28.14 +0.71 (+2.59%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 28.14 unch (unch) 16:01 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,207 | -13,183 | -33,277 | -25,175 | -15,439 |
| Depreciation Amortization | 1,363 | 605 | 2,770 | 2,195 | 1,428 |
| Accounts receivable | N/A | N/A | -2,624 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | -4,208 | N/A | N/A |
| Other Working Capital | -18,285 | 607 | -33,370 | -27,389 | -26,938 |
| Other Operating Activity | 1,702 | 975 | 10,777 | 3,370 | 2,728 |
| Operating Cash Flow | $-24,427 | $-10,996 | $-59,932 | $-46,999 | $-38,221 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -115 | -48 | -1,041 | -1,052 | -1,018 |
| Purchase Of Investment | -8,243 | -1,544 | -48,395 | -43,191 | -31,645 |
| Sale Of Investment | 18,895 | 13,495 | 28,200 | 21,900 | 4,850 |
| Investing Cash Flow | $10,537 | $11,903 | $-21,236 | $-22,343 | $-27,813 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 19,781 | N/A | 7,214 | 7,121 | 6,839 |
| Financing Cash Flow | $19,781 | $N/A | $7,214 | $7,121 | $6,839 |
| Exchange Rate Effect | 412 | 200 | -5,175 | -7,120 | -4,312 |
| Beginning Cash Position | 38,635 | 38,635 | 117,764 | 117,764 | 117,764 |
| End Cash Position | 44,938 | 39,742 | 38,635 | 48,423 | 54,257 |
| Net Cash Flow | $6,303 | $1,107 | $-79,129 | $-69,341 | $-63,507 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,427 | -10,996 | -59,932 | -46,999 | -38,221 |
| Capital Expenditure | -115 | -48 | -1,041 | -1,052 | -1,018 |
| Free Cash Flow | -24,542 | -11,044 | -60,973 | -48,051 | -39,239 |